| 000 | 00859 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517131153.0 | ||
| 264 | 0 | _c20180116 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2016-11-745323 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLittle, Richard F | |
| 245 | 0 | 0 |
_aMeasure for measure: minimal residual disease in CLL. _h[electronic resource] |
| 260 |
_bBlood _c12 2016 |
||
| 300 |
_a2747-2748 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 | _aLeukemia, Lymphocytic, Chronic, B-Cell |
| 650 | 0 | 4 | _aNeoplasm, Residual |
| 700 | 1 | _aMcShane, Lisa M | |
| 773 | 0 |
_tBlood _gvol. 128 _gno. 24 _gp. 2747-2748 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2016-11-745323 _zAvailable from publisher's website |
| 999 |
_c26701514 _d26701514 |
||